Apheresis as Therapy
Aferetica is an Innovative Small and Medium-sized Enterprise (SME), founded by Managers with tens of years of experience in Dialysis, Intensive Care, Cardiology and Medical Devices.
The company proposes itself as a catalyst for the creation of a Network of Clinicians, Academics, Researchers and Institutions, to create and validate New Apheretic Therapies, even for unexplored clinical areas.
An integrated and innovative vision of apheretic therapies is the challenge to face for a real evolution of the cure.
Contribute to research for the development, creation and diffusion of complete apheretic therapies.
For a concrete breakthrough in organ availability and transplantation outcome.
Apheresis as therapy: new frontiers in critically ill patients.
Aferetica will attend the next SITO congress, Rome, 21th-23th November.